PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
GHRS vs. SEEL
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between GHRS and SEEL is 0.12, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.1

Performance

GHRS vs. SEEL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in GH Research PLC (GHRS) and Seelos Therapeutics, Inc. (SEEL). The values are adjusted to include any dividend payments, if applicable.

-100.00%-90.00%-80.00%-70.00%-60.00%-50.00%-40.00%JulyAugustSeptemberOctoberNovemberDecember
-64.42%
-100.00%
GHRS
SEEL

Key characteristics

Fundamentals

Market Cap

GHRS:

$440.16M

SEEL:

$214.97K

EPS

GHRS:

-$0.79

SEEL:

$351.04

Total Revenue (TTM)

GHRS:

$80.00K

SEEL:

$1.61M

Gross Profit (TTM)

GHRS:

-$156.00K

SEEL:

$1.56M

EBITDA (TTM)

GHRS:

-$40.70M

SEEL:

-$17.16M

Returns By Period


GHRS

YTD

18.10%

1M

-37.44%

6M

-41.95%

1Y

29.73%

5Y*

N/A

10Y*

N/A

SEEL

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

GHRS vs. SEEL - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for GH Research PLC (GHRS) and Seelos Therapeutics, Inc. (SEEL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for GHRS, currently valued at 0.42, compared to the broader market-4.00-2.000.002.000.42-0.63
The chart of Sortino ratio for GHRS, currently valued at 1.03, compared to the broader market-4.00-2.000.002.004.001.03-4.20
The chart of Omega ratio for GHRS, currently valued at 1.13, compared to the broader market0.501.001.502.001.130.53
The chart of Calmar ratio for GHRS, currently valued at 0.35, compared to the broader market0.002.004.006.000.35-1.00
The chart of Martin ratio for GHRS, currently valued at 1.03, compared to the broader market-5.000.005.0010.0015.0020.0025.001.03-1.19
GHRS
SEEL


Rolling 12-month Sharpe Ratio-0.500.000.501.00JulyAugustSeptemberOctoberNovemberDecember
0.42
-0.63
GHRS
SEEL

Dividends

GHRS vs. SEEL - Dividend Comparison

Neither GHRS nor SEEL has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

GHRS vs. SEEL - Drawdown Comparison


-100.00%-90.00%-80.00%-70.00%-60.00%JulyAugustSeptemberOctoberNovemberDecember
-75.45%
-100.00%
GHRS
SEEL

Volatility

GHRS vs. SEEL - Volatility Comparison

GH Research PLC (GHRS) has a higher volatility of 25.21% compared to Seelos Therapeutics, Inc. (SEEL) at 0.00%. This indicates that GHRS's price experiences larger fluctuations and is considered to be riskier than SEEL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%20.00%40.00%60.00%80.00%100.00%JulyAugustSeptemberOctoberNovemberDecember
25.21%
0
GHRS
SEEL

Financials

GHRS vs. SEEL - Financials Comparison

This section allows you to compare key financial metrics between GH Research PLC and Seelos Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab